acetyl-l-carnitine diabetic neuropathy rct doi L-Carnitine Prevention and Management Strategies for
Description
However, the etiology and pathogenesis of IgAVN are not clear
2003;123:21S49S
[DOI] [Google Scholar] 98.Ueno K., Yamaoka H., Hayashi K., Okamura S
In the first study, 53.1% of patients in the treatment group entered remission vs
